The pancreas secretes both insulin and amylin, so should an artificial pancreas system provide insulin and pramlintide?

The new approval of Wegovy™ is for a current medication, semaglutide, but more than doubling the standard dose for diabetes treatment. 

SURPASS-4 is a randomized controlled trial of tirzepatide once a week vs. insulin glargine once a day in type 2 diabetes patients with high cardiovascular risk.

A study aims to establish whether bariatric surgery can reduce adverse cardiovascular events. 

Pyroptosis causes cell death, leading to beta-cell dysfunction and diabetes mellitus.

Study finds incidence of type 2 diabetes reduced by 32% in participants taking dapagliflozin vs. placebo. 

A recently published study suggests that supplementation with select strains of naturally occurring gut bacteria may improve postprandial glucose control in patients with T2DM.

Intensive insulin therapy may speed up the development of diabetic retinopathy, placing some patients at a higher risk for blindness. 

Telemedicine provides a vital channel for supporting elderly diabetes patients during a worldwide pandemic, but may also pose some challenges.

Central adiposity shows varying effects on blood pressure, LDL cholesterol, and glycemic profile.